HomeCompareEW vs TT

EW vs TT: Dividend Comparison 2026

EW yields 2.51% · TT yields 0.95%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TT wins by $266.4K in total portfolio value· pulled ahead in Year 3
10 years
EW
EW
● Live price
2.51%
Share price
$79.71
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.4K
Annual income
$295.02
Full EW calculator →
TT
TT
● Live price
0.95%
Share price
$408.75
Annual div
$3.87
5Y div CAGR
77.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$289.8K
Annual income
$172,446.82
Full TT calculator →

Portfolio growth — EW vs TT

📍 TT pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEWTT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EW + TT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EW pays
TT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EW
Annual income on $10K today (after 15% tax)
$213.27/yr
After 10yr DRIP, annual income (after tax)
$250.77/yr
TT
Annual income on $10K today (after 15% tax)
$80.48/yr
After 10yr DRIP, annual income (after tax)
$146,579.80/yr
At 15% tax rate, TT beats the other by $146,329.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EW + TT for your $10,000?

EW: 50%TT: 50%
100% TT50/50100% EW
Portfolio after 10yr
$156.6K
Annual income
$86,370.92/yr
Blended yield
55.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EW right now

EW
Analyst Ratings
32
Buy
16
Hold
Consensus: Buy
Price Target
$96.38
+20.9% upside vs current
Range: $87.00 — $110.00
Altman Z
10.9
Piotroski
5/9
TT
Analyst Ratings
10
Buy
14
Hold
1
Sell
Consensus: Hold
Price Target
$471.88
+15.4% upside vs current
Range: $370.00 — $520.00
Altman Z
6.6
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EW buys
10
TT buys
7
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$EW▼ Sell$1,001 - $15,0002025-11-19
Ro Khanna🏢 House$EW▼ Sell$1,001 - $15,0002025-10-07
Bruce Westerman🏢 House$EW▼ Sell$1,001 - $15,0002025-04-21
Rob Bresnahan🏢 House$EW▲ Buy$1,001 - $15,0002025-04-08
Jefferson Shreve🏢 House$EW▲ Buy$15,001 - $50,0002025-04-07
Bruce Westerman🏢 House$EW▲ Buy$1,001 - $15,0002025-03-03
Josh Gottheimer🏢 House$TT▼ Sell$1,001 - $15,0002024-12-23
Josh Gottheimer🏢 House$TT▼ Sell$1,001 - $15,0002024-12-05
Valerie Hoyle🏢 House$TT▲ Buy$1,001 - $15,0002024-10-29
Ro Khanna🏢 House$EW▲ Buy$1,001 - $15,0002024-10-14
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEWTT
Forward yield2.51%0.95%
Annual dividend / share$2.00$3.87
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%77.2%
Portfolio after 10y$23.4K$289.8K
Annual income after 10y$295.02$172,446.82
Total dividends collected$2.7K$258.8K
Payment frequencyquarterlyquarterly
SectorHealthcareIndustrials
Analyst consensusBuyHold
Analyst price target$96.38$471.88

Year-by-year: EW vs TT ($10,000, DRIP)

YearEW PortfolioEW Income/yrTT PortfolioTT Income/yrGap
1$10,951$250.91$10,868$167.77+$83.00EW
2$11,974$256.79$11,930$301.96+$44.00EW
3← crossover$13,075$262.42$13,315$548.96$240.00TT
4$14,258$267.80$15,261$1,014.59$1.0KTT
5$15,529$272.92$18,255$1,925.88$2.7KTT
6$16,894$277.80$23,348$3,815.15$6.5KTT
7$18,359$282.45$33,064$8,080.87$14.7KTT
8$19,931$286.86$54,329$18,951.00$34.4KTT
9$21,617$291.05$109,702$51,569.63$88.1KTT
10$23,425$295.02$289,828$172,446.82$266.4KTT

EW vs TT: Complete Analysis 2026

EWHealthcare

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Full EW Calculator →

TTIndustrials

Trane Technologies plc, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of solutions for heating, ventilation, air conditioning, and transport refrigeration. It offers air conditioners, exchangers, and handlers; airside and terminal devices; auxiliary power units; chillers; coils and condensers; gensets; furnaces; heat pumps; home automation products; humidifiers; hybrid and non-diesel transport refrigeration, and ice energy storage solutions; indoor air quality assessments and related products; large and light commercial unitary products; motor replacements; refrigerant reclamation products; thermostats/controls; transport heater products; variable refrigerant flow products; and water source heat pumps. The company also provides building management, control, ductless, geothermal, package heating and cooling, temporary heating and cooling, and unitary systems; bus, rail, and multi-pipe heating, ventilation, and air conditioning systems; and container, cryogenic, diesel-powered, electric-powered trailer and truck, hybrid-powered trailer, industrial, rail, self-powered truck, trailer, and vehicle-powered truck refrigeration systems, as well as aftermarket and OEM parts and supplies. In addition, it offers energy and facility management, installation and performance contracting, repair and maintenance, and rental services. It markets and sells its products under the Trane and Thermo King brands through sales offices, distributors, and dealers in the United States; and through sales and service companies with a supporting chain of distributors worldwide. The company was formerly known as Ingersoll-Rand Plc and changed its name to Trane Technologies plc in March 2020. Trane Technologies plc was founded in 1885 and is headquartered in Swords, Ireland.

Full TT Calculator →
📬

Get this EW vs TT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EW vs SCHDEW vs JEPIEW vs OEW vs KOEW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.